Log In
Print
BCIQ
Print
Print this Print this
 

ALT-803

  Manage Alerts
Collapse Summary General Information
Company Altor BioScience Corp.
DescriptionIL-15 mutant agonist complexed to an Fc fusion protein of IL-15 receptor a-chain (IL-15RA)
Molecular Target Interleukin-15 (IL-15)
Mechanism of ActionInterleukin-15 (IL-15) agonist
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$209.0M

$4.0M

$200.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today